Key result
Innate and adaptive immune mechanisms actively drive every stage of atherosclerotic plaque progression.
Answers are grounded in this paper and cite their sources.
This review highlights the critical role of both innate and adaptive immune responses in the evolution of atherosclerotic plaques, providing insights for potential immunomodulatory therapeutic strategies.
Atherosclerosis serves as the primary catalyst for numerous cardiovascular diseases. Growing evidence suggests that the immune response is involved in every stage of atherosclerotic plaque evolution. Rapid, but not specific, innate immune arms, including neutrophils, monocytes/macrophages, dendritic cells (DCs) and other innate immune cells, as well as pattern-recognition receptors and various inflammatory mediators, contribute to atherogenesis. The specific adaptive immune response, governed by T cells and B cells, antibodies, and immunomodulatory cytokines potently regulates disease activity and progression. In the inflammatory microenvironment, the heterogeneity of leukocyte subpopulations plays a very important regulatory role in plaque evolution. With advances in experimental techniques, the fine mechanisms of immune system involvement in atherosclerotic plaque evolution are becoming known. In this review, we examine the critical immune responses involved in atherosclerotic plaque evolution, in particular, looking at atherosclerosis from the perspective of evolutionary immunobiology. A comprehensive understanding of the interplay between plaque evolution and plaque immunity provides clues for strategically combating atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Pi et al. (2024) conducted a review in Atherosclerosis. Both innate and adaptive immune responses, including leukocyte subpopulations and inflammatory mediators, play a critical regulatory role in every stage of atherosclerotic plaque evolution.
Synapse has enriched 10 related papers. Consider them for comparative context: